Interferon-γ (IFN-γ) excessive production is nullified by using Emapalumab in children suffering from hemophagocytic lymphohistiocytosis (HLH) and keeps the children alive until a transplant can be made (di Lorenzo et al., 2020). The gene discussed is IFNG; the disease is hemophagocytic syndrome.